4月20日～4月26日の間に収集した論文情報を追加しました。(3/3)
①PEGylated versus non-PEGylated drugs: A cross-sectional analysis of adverse events in the FDA Adverse Event Reporting System (FAERS) Database.
ペグ化薬物と非ペグ化薬物の有害事象横断分析
対象DB：FAERS
②Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death.
エスゾピクロン、ザレプロン、ゾルピデムに関連する死亡転帰などをもたらす複雑な睡眠行動のケース特定分析
③Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database.
COVID-19の治療のためのクロロキンによる神経精神医学的有害事象関連調査
④Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system.
サクビトリル/バルサルタンによる有害事象調査研究
⑤Mining Drugs and Indications for Suicide-Related Adverse Events.
薬物と適応症を自殺の危険因子したファーマコビジランス分析
対象DB：FAERS,AEOLUS
Date
(PubMed追加日)
